Ira Spector

Chief Strategy Officer at SFA Therapeutics, Inc

SFA Therapeutics· Summer 2021Greater Philadelphia

in LinkedIn

2017CEO· SFA Therapeutics

In tech · since 1988

Company

SFA Therapeutics

Role

CEO

current

Stage

—

no public source

Raised

—

no public source

Based

Jenkintown, PA

current

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

SFA Therapeutics

Regulating the immune system to block cancer & autoimmune diseases

Summer 2021

Experience

Career

SFA Therapeutics
CEO · Jenkintown, PA · 2017 – Present
2017
ICON plc
Executive Vice President, Analytics & Consulting · North Wales, PA · 2014 – 2017
2014
Allergan
Senior Vice President, Global Development Operations · Irvine, CA · 2010 – 2014
2010
Pfizer
Vice President, Global Development Operations at Wyeth Research · Collegeville, PA · 1993 – 2010
1993
PA Consulting Group
Partner, Vice President U.S. Healthcare Practice · Princeton, NJ · 1990 – 1993
1990
Mars Electronics
Manager, Producibility Engineering Department · West Chester, Pennsylvania · 1988 – 1990
1988
Air Products and Chemicals
Business Manager, Infrared Materials · Trexlertown, PA · 1978 – 1988
1988

Bio

Dr. Spector is the co-founder of SFA, a microbiome-derived pharmaceutical company focused on new advancements in the treatment inflammatory diseases. An experienced drug developer with over 30 years of experience, he helped develop 34 drugs and 12 medical devices, including Enbrel, Effexor, Protonix, Prevenar, Ozurdex, Botox for Overactive Bladder, Chronic Migraine and Cerebral Palsy. He holds BS degrees in Physics and EE from Washington University, an MBA from Drexel, and a PhD from Rutgers.